Unknown

Dataset Information

Identification of Macrolepiota procera extract as a novel G6PD inhibitor for the treatment of lung cancer.


ABSTRACT: Tumor metabolism, an emerging hallmark of cancer, is characterized by aberrant expression of enzymes from various metabolic pathways including glycolysis and PPP (pentose phosphate pathway). Glucose 6 phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase (6PGD), oxidative carboxylases of PPP, have been reported to accomplish different biosynthetic and energy requirements of cancer cells. G6PD and 6PGD have been proposed as potential therapeutic targets for cancer therapy during recent years due to their overexpression in various cancers. Here, we have employed enzymatic assay based screening using in-house G6PD and 6PGD assay protocols for the identification of mushroom extracts which could inhibit G6PD or 6PGD enzymatic activity for implications in cancer therapy. For the fu

SUBMITTER: Zara R 

PROVIDER: S-EPMC9295138 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature